Benzinga | Aug 13, 2020 04:13PM EDT

Arcadia Biosciences Q2 EPS $(1.04) May Not Compare To $(0.59) Estimate, Sales $281.00K Up From $203.00K YoY

Arcadia Biosciences (NASDAQ:RKDA) reported quarterly losses of $(1.04) per share which missed the analyst consensus estimate of $(0.59) by 76.27 percent. This is a 223.81 percent decrease over earnings of $0.84 per share from the same period last year. The company reported $281.00 thousand in sales this quarter. This is a 38.42 percent increase over sales of $203.00 thousand the same period last year.